Association between parental anthropometric measures and the outcomes of intracytoplasmic sperm injection cycles

  • Amanda Setti
  • Gabriela Halpern
  • Daniela Braga
  • Rita Figueira
  • Assumpto IaconelliJr
  • Edson BorgesJrEmail author
Assisted Reproduction Technologies



To study the association between body mass index (BMI), waist circumference (WC), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR), and response to controlled ovarian stimulation, semen quality, and intracytoplasmic sperm injection (ICSI) outcomes.


This prospective observational study included data from 402 couples undergoing ICSI between January/2010–September/2016. Participants had their weight, height, waist, and hip measured before ICSI treatment.


Gonadotropin dose was positively associated with maternal WHR. Maternal WC and WHR negatively influenced the estradiol level, number of follicles, oocytes, and mature oocytes. Maternal BMI negatively influenced oocyte yield. Semen volume was negatively influenced by male BMI. Sperm concentration was negatively associated with WHR and WHtR. Progressive sperm motility was negatively influenced by all anthropometric measures (AMs). The TMSC was negatively affected by all AM but WC. Significant differences were observed in all ICSI outcomes except pregnancy and miscarriage rates, favoring women with AM below the cut off values compared to women above the cut off. It was observed that men with AM below the cut off values showed significantly higher rates of fertilization, embryo and blastocyst development, implantation, and pregnancy than men above the cut off. When combined maternal and paternal AM were analyzed, significant differences were observed in fertilization, embryo and blastocyst development and implantation rates, favoring couples with normal BMI, WC, and WHR.


Lower AMs have a protective effect on fertility. Awareness and counseling on how to minimize its impact in both partners could improve ICSI outcomes.


Anthropometric measures Infertility Intracytoplasmic sperm injection Lifestyle 


Compliance with ethical standards

A written informed consent was obtained in which patients agreed to share the outcomes of their own cycles for research purposes, and the study was approved by the local Institutional Review Board (410/2010).


  1. 1.
    World Health Organization. Obesity : preventing and managing the global epidemic : report of a WHO consultation. . Geneva1999.Google Scholar
  2. 2.
    Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79:379–84.CrossRefPubMedGoogle Scholar
  3. 3.
    Alberti KG, Zimmet P, Shaw J, Group IDFETFC. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366:1059–62.CrossRefGoogle Scholar
  4. 4.
    World Health Organization. Waist circumference and waist–hip ratio: report of a WHO expert consultation. Geneva: WHO; 2008.Google Scholar
  5. 5.
    Ashwell M, Cole TJ, Dixon AK. Ratio of waist circumference to height is strong predictor of intra-abdominal fat. BMJ. 1996;313:559–60.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed). 1984;288:1401–4.CrossRefGoogle Scholar
  7. 7.
    Savva SC, Lamnisos D, Kafatos AG. Predicting cardiometabolic risk: waist-to-height ratio or BMI. A meta-analysis. Diabetes Metab Syndr Obes. 2013;6:403–19.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg. Sweden Br Med J (Clin Res Ed). 1984;289:1257–61.CrossRefGoogle Scholar
  9. 9.
    Brewer CJ, Balen AH. The adverse effects of obesity on conception and implantation. Reproduction. 2010;140:347–64.CrossRefPubMedGoogle Scholar
  10. 10.
    Sundaram R, Mumford SL, Buck Louis GM. Couples’ body composition and time-to-pregnancy. Hum Reprod. 2017;32:662–8.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Bellver J, Melo MA, Bosch E, Serra V, Remohi J, Pellicer A. Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil Steril. 2007;88:446–51.CrossRefPubMedGoogle Scholar
  12. 12.
    Bellver J, Rossal LP, Bosch E, Zuniga A, Corona JT, Melendez F, et al. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril. 2003;79:1136–40.CrossRefPubMedGoogle Scholar
  13. 13.
    DeUgarte DA, DeUgarte CM, Sahakian V. Surrogate obesity negatively impacts pregnancy rates in third-party reproduction. Fertil Steril. 2010;93:1008–10.CrossRefPubMedGoogle Scholar
  14. 14.
    Metwally M, Tuckerman EM, Laird SM, Ledger WL, Li TC. Impact of high body mass index on endometrial morphology and function in the peri-implantation period in women with recurrent miscarriage. Reprod BioMed Online. 2007;14:328–34.CrossRefPubMedGoogle Scholar
  15. 15.
    Sermondade N, Faure C, Fezeu L, Shayeb AG, Bonde JP, Jensen TK, et al. BMI in relation to sperm count: an updated systematic review and collaborative meta-analysis. Hum Reprod Update. 2013;19:221–31.CrossRefPubMedGoogle Scholar
  16. 16.
    Mushtaq R, Pundir J, Achilli C, Naji O, Khalaf Y, El-Toukhy T. Effect of male body mass index on assisted reproduction treatment outcome: an updated systematic review and meta-analysis. Reprod BioMed Online. 2018.Google Scholar
  17. 17.
    Eisenberg ML, Kim S, Chen Z, Sundaram R, Schisterman EF, Buck Louis GM. The relationship between male BMI and waist circumference on semen quality: data from the LIFE study. Hum Reprod. 2014;29:193–200.CrossRefPubMedGoogle Scholar
  18. 18.
    Fejes I, Koloszar S, Szollosi J, Zavaczki Z, Pal A. Is semen quality affected by male body fat distribution? Andrologia. 2005;37:155–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Hammiche F, Laven JS, Twigt JM, Boellaard WP, Steegers EA, Steegers-Theunissen RP. Body mass index and central adiposity are associated with sperm quality in men of subfertile couples. Hum Reprod. 2012;27:2365–72.CrossRefPubMedGoogle Scholar
  20. 20.
    Ehala-Aleksejev K, Punab M. Relationships between total testicular volume, reproductive parameters and surrogate measures of adiposity in men presenting for couple’s infertility. Andrologia. 2017.Google Scholar
  21. 21.
    Hartz AJ, Rupley DC, Rimm AA. The association of girth measurements with disease in 32,856 women. Am J Epidemiol. 1984;119:71–80.CrossRefPubMedGoogle Scholar
  22. 22.
    Zaadstra BM, Seidell JC, Van Noord PA, te Velde ER, Habbema JD, Vrieswijk B, et al. Fat and female fecundity: prospective study of effect of body fat distribution on conception rates. BMJ. 1993;306:484–7.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    World Health Organization. The WHO STEPwise approach to noncommunicable disease risk factor surveillance 2017 [updated 26 January 2017.Google Scholar
  24. 24.
    World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. 2000:253.Google Scholar
  25. 25.
    Raman R, Rani PK, Gnanamoorthy P, Sudhir RR, Kumaramanikavel G, Sharma T. Association of obesity with diabetic retinopathy: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetics study (SN-DREAMS report no. 8). Acta Diabetol. 2010;47:209–15.CrossRefPubMedGoogle Scholar
  26. 26.
    Adab P, Pallan M, Whincup PH. Is BMI the best measure of obesity? BMJ. 2018;360:k1274.CrossRefPubMedGoogle Scholar
  27. 27.
    Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol. 2018;16:22.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Kirchengast S, Huber J. Body composition characteristics and fat distribution patterns in young infertile women. Fertil Steril. 2004;81:539–44.CrossRefPubMedGoogle Scholar
  29. 29.
    Pinborg A, Gaarslev C, Hougaard CO, Nyboe Andersen A, Andersen PK, Boivin J, et al. Influence of female bodyweight on IVF outcome: a longitudinal multicentre cohort study of 487 infertile couples. Reprod BioMed Online. 2011;23:490–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Depalo R, Garruti G, Totaro I, Panzarino M, Vacca MP, Giorgino F, et al. Oocyte morphological abnormalities in overweight women undergoing in vitro fertilization cycles. Gynecol Endocrinol. 2011;27:880–4.CrossRefPubMedGoogle Scholar
  31. 31.
    Singh N, Gupta P, Mittal S, Malhotra N. Correlation of body mass index with outcome of in vitro fertilization in a developing country. Arch Gynecol Obstet. 2012;285:259–63.CrossRefPubMedGoogle Scholar
  32. 32.
    Esinler I, Bozdag G, Yarali H. Impact of isolated obesity on ICSI outcome. Reprod BioMed Online. 2008;17:583–7.CrossRefPubMedGoogle Scholar
  33. 33.
    Sneed ML, Uhler ML, Grotjan HE, Rapisarda JJ, Lederer KJ, Beltsos AN. Body mass index: impact on IVF success appears age-related. Hum Reprod. 2008;23:1835–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Setti AS, Braga DP, Figueira Rde C, Vingris L, Iaconelli A, Borges E, Jr. Body mass index is negatively correlated with the response to controlled ovarian stimulation but does not influence oocyte morphology in ICSI cycles. Eur J Obstet Gynecol Reprod Biol 2012;163:175–179.CrossRefGoogle Scholar
  35. 35.
    Amsiejiene A, Drasutiene G, Usoniene A, Tutkuviene J, Vilsinskaite S, Barskutyte L. The influence of age, body mass index, waist-to-hip ratio and anti-Mullerian hormone level on clinical pregnancy rates in ART. Gynecol Endocrinol. 2017;33:41–3.CrossRefPubMedGoogle Scholar
  36. 36.
    Provost MP, Acharya KS, Acharya CR, Yeh JS, Steward RG, Eaton JL, et al. Pregnancy outcomes decline with increasing recipient body mass index: an analysis of 22,317 fresh donor/recipient cycles from the 2008-2010 Society for Assisted Reproductive Technology Clinic Outcome Reporting System registry. Fertil Steril. 2016;105:364–8.CrossRefPubMedGoogle Scholar
  37. 37.
    Rittenberg V, Seshadri S, Sunkara SK, Sobaleva S, Oteng-Ntim E, El-Toukhy T. Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reprod BioMed Online. 2011;23:421–39.CrossRefPubMedGoogle Scholar
  38. 38.
    Pasquali R, Gambineri A. Metabolic effects of obesity on reproduction. Reprod BioMed Online. 2006;12:542–51.CrossRefPubMedGoogle Scholar
  39. 39.
    Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC. The insulin-related ovarian regulatory system in health and disease. Endocr Rev. 1999;20:535–82.CrossRefPubMedGoogle Scholar
  40. 40.
    Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998;392:398–401.CrossRefGoogle Scholar
  41. 41.
    Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med. 1999;341:879–84.CrossRefPubMedGoogle Scholar
  42. 42.
    Moschos S, Chan JL, Mantzoros CS. Leptin and reproduction: a review. Fertil Steril. 2002;77:433–44.CrossRefPubMedGoogle Scholar
  43. 43.
    Agarwal SK, Vogel K, Weitsman SR, Magoffin DA. Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granulosa and theca cells of the human ovary. J Clin Endocrinol Metab. 1999;84:1072–6.PubMedGoogle Scholar
  44. 44.
    Swain JE, Dunn RL, McConnell D, Gonzalez-Martinez J, Smith GD. Direct effects of leptin on mouse reproductive function: regulation of follicular, oocyte, and embryo development. Biol Reprod. 2004;71:1446–52.CrossRefPubMedGoogle Scholar
  45. 45.
    Zachow RJ, Magoffin DA. Direct intraovarian effects of leptin: impairment of the synergistic action of insulin-like growth factor-I on follicle-stimulating hormone-dependent estradiol-17 beta production by rat ovarian granulosa cells. Endocrinology. 1997;138:847–50.CrossRefPubMedGoogle Scholar
  46. 46.
    Duggal PS, Van Der Hoek KH, Milner CR, Ryan NK, Armstrong DT, Magoffin DA, et al. The in vivo and in vitro effects of exogenous leptin on ovulation in the rat. Endocrinology. 2000;141:1971–6.CrossRefPubMedGoogle Scholar
  47. 47.
    Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A. 2001;98:6390–5.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Van Blerkom J, Antczak M, Schrader R. The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod. 1997;12:1047–55.CrossRefPubMedGoogle Scholar
  49. 49.
    Tamer Erel C, Senturk LM. The impact of body mass index on assisted reproduction. Curr Opin Obstet Gynecol. 2009;21:228–35.CrossRefPubMedGoogle Scholar
  50. 50.
    Lu JC, Jing J, Dai JY, Zhao AZ, Yao Q, Fan K, et al. Body mass index, waist-to-hip ratio, waist circumference and waist-to-height ratio cannot predict male semen quality: a report of 1231 subfertile Chinese men. Andrologia. 2015;47:1047–54.CrossRefPubMedGoogle Scholar
  51. 51.
    Davidson LM, Millar K, Jones C, Fatum M, Coward K. Deleterious effects of obesity upon the hormonal and molecular mechanisms controlling spermatogenesis and male fertility. Hum Fertil (Camb). 2015;18:184–93.CrossRefGoogle Scholar
  52. 52.
    Chavarro JE, Toth TL, Wright DL, Meeker JD, Hauser R. Body mass index in relation to semen quality, sperm DNA integrity, and serum reproductive hormone levels among men attending an infertility clinic. Fertil Steril. 2010;93:2222–31.CrossRefPubMedGoogle Scholar
  53. 53.
    Hajshafiha M, Ghareaghaji R, Salemi S, Sadegh-Asadi N, Sadeghi-Bazargani H. Association of body mass index with some fertility markers among male partners of infertile couples. Int J Gen Med. 2013;6:447–51.PubMedPubMedCentralGoogle Scholar
  54. 54.
    Jensen TK, Andersson AM, Jorgensen N, Andersen AG, Carlsen E, Petersen JH, et al. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril. 2004;82:863–70.CrossRefPubMedGoogle Scholar
  55. 55.
    Pasquali R, Patton L, Gambineri A. Obesity and infertility. Curr Opin Endocrinol Diabetes Obes. 2007;14:482–7.CrossRefPubMedGoogle Scholar
  56. 56.
    Winters SJ, Wang C, Abdelrahaman E, Hadeed V, Dyky MA, Brufsky A. Inhibin-B levels in healthy young adult men and prepubertal boys: is obesity the cause for the contemporary decline in sperm count because of fewer Sertoli cells? J Androl. 2006;27:560–4.CrossRefPubMedGoogle Scholar
  57. 57.
    Du Plessis SS, Cabler S, McAlister DA, Sabanegh E, Agarwal A. The effect of obesity on sperm disorders and male infertility. Nat Rev Urol. 2010;7:153–61.CrossRefPubMedGoogle Scholar
  58. 58.
    Bakos HW, Mitchell M, Setchell BP, Lane M. The effect of paternal diet-induced obesity on sperm function and fertilization in a mouse model. Int J Androl. 2011;34:402–10.CrossRefPubMedGoogle Scholar
  59. 59.
    Tunc O, Tremellen K. Oxidative DNA damage impairs global sperm DNA methylation in infertile men. J Assist Reprod Genet. 2009;26:537–44.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Fariello RM, Pariz JR, Spaine DM, Cedenho AP, Bertolla RP, Fraietta R. Association between obesity and alteration of sperm DNA integrity and mitochondrial activity. BJU Int. 2012;110:863–7.CrossRefPubMedGoogle Scholar
  61. 61.
    La Vignera S, Condorelli RA, Vicari E, Calogero AE. Negative effect of increased body weight on sperm conventional and nonconventional flow cytometric sperm parameters. J Androl. 2012;33:53–8.CrossRefPubMedGoogle Scholar
  62. 62.
    Balen AH, Anderson RA, Policy, Practice committee of the BFS. Impact of obesity on female reproductive health: British fertility society, policy and practice guidelines. Hum Fertil (Camb) 2007;10:195–206.Google Scholar
  63. 63.
    Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X, et al. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod. 1995;10:2705–12.CrossRefPubMedGoogle Scholar
  64. 64.
    Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod. 1998;13:1502–5.CrossRefPubMedGoogle Scholar
  65. 65.
    Guzick DS, Wing R, Smith D, Berga SL, Winters SJ. Endocrine consequences of weight loss in obese, hyperandrogenic. anovulatory women Fertil Steril. 1994;61:598–604.CrossRefPubMedGoogle Scholar
  66. 66.
    Hollmann M, Runnebaum B, Gerhard I. Effects of weight loss on the hormonal profile in obese, infertile women. Hum Reprod. 1996;11:1884–91.CrossRefPubMedGoogle Scholar
  67. 67.
    Tang T, Glanville J, Hayden CJ, White D, Barth JH, Balen AH. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod. 2006;21:80–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Fertility Medical GroupSao PauloBrazil
  2. 2.Sapientiae InstituteSao PauloBrazil

Personalised recommendations